Dr Reddy's recalls anti-seizure drug in the US market

Dr Reddy's Laboratories Limited has started recalling anti-seizure drug Divalproex extended release tablets from the US market owing to cGMP deviations noticed in certain batches of the product.

According to information posted on the US Food and Drug Administration(USFDA), the company initiated a voluntary recall of Divalproex 100-count and 500-count bottles, totaling 33,958 bottles on April 11, 2019 after finding out that the product was exposed to huimdity levels above 50 percent during packaging.

Categorised as class II recall, the noticed deviation presents a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse